Donald S. Higgins, MD, PhD - Publications

Affiliations: 
Neurology Albany Medical Center, Albany, NY, United States 

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Molecular Neurodegeneration. 10: 50. PMID 26399558 DOI: 10.1186/s13024-015-0045-4  0.96
2013 Seegal RF, Fitzgerald EF, McCaffrey RJ, Shrestha S, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons PJ, Molho ES, Higgins DS, Factor SA, Seibyl JP. Tibial bone lead, but not serum polychlorinated biphenyl, concentrations are associated with neurocognitive deficits in former capacitor workers. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 55: 552-62. PMID 23618890 DOI: 10.1097/JOM.0b013e318285f3fd  0.96
2012 Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1797-800. PMID 23124580 DOI: 10.1002/mds.25237  0.96
2011 Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2190-5. PMID 21714002 DOI: 10.1002/mds.23806  0.96
2011 Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 564-8. PMID 20884673 DOI: 10.1136/jnnp.2010.222042  0.96
2011 Seegal RF, Fitzgerald EF, Hills EA, Wolff MS, Haase RF, Todd AC, Parsons P, Molho ES, Higgins DS, Factor SA, Marek KL, Seibyl JP, Jennings DL, McCaffrey RJ. Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. Journal of Exposure Science & Environmental Epidemiology. 21: 234-46. PMID 20216575 DOI: 10.1038/jes.2010.3  0.96
2010 Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Archives of Neurology. 67: 1350-6. PMID 21060011 DOI: 10.1001/archneurol.2010.279  0.96
2010 Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, Higgins DS, Gancher S, Moses L, Zareparsi S, Poorkaj P, et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology. 75: 1189-94. PMID 20876472 DOI: 10.1212/WNL.0b013e3181f4d832  0.96
2010 Sadjadi R, Rose MR. What determines quality of life in inclusion body myositis? Journal of Neurology, Neurosurgery, and Psychiatry. 81: 1164-6. PMID 20601666 DOI: 10.1136/jnnp.2009.183863  0.96
2010 Seegal RF, Marek KL, Seibyl JP, Jennings DL, Molho ES, Higgins DS, Factor SA, Fitzgerald EF, Hills EA, Korrick SA, Wolff MS, Haase RF, Todd AC, Parsons P, McCaffrey RJ. Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging study. Neurobiology of Disease. 38: 219-25. PMID 20096358 DOI: 10.1016/j.nbd.2010.01.009  0.96
2009 Molho ES, Agarwal N, Regan K, Higgins DS, Factor SA. Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1384-7. PMID 19441129 DOI: 10.1002/mds.22622  0.96
2008 Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG, Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 1222-30. PMID 18404644 DOI: 10.1002/ajmg.b.30758  0.96
2008 McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H. Exploring gene-environment interactions in Parkinson's disease. Human Genetics. 123: 257-65. PMID 18210157 DOI: 10.1007/s00439-008-0466-z  0.96
2008 Hutter CM, Samii A, Factor SA, Nutt JG, Higgins DS, Bird TD, Griffith A, Roberts JW, Leis BC, Montimurro JS, Kay DM, Edwards KL, Payami H, Zabetian CP. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 15: 134-9. PMID 18093156 DOI: 10.1111/j.1468-1331.2007.02012.x  0.96
2008 Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 88-95. PMID 17987647 DOI: 10.1002/mds.21782  0.96
2007 Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology. 62: 137-44. PMID 17514749 DOI: 10.1002/ana.21157  0.96
2007 Langbehn DR, Paulsen JS. Predictors of diagnosis in Huntington disease. Neurology. 68: 1710-7. PMID 17502553 DOI: 10.1212/01.wnl.0000261918.90053.96  0.96
2007 Cardona-Garcia OD, Higgins DS, Molho ES. Botulinum toxin in the management of dystonia. Current Treatment Options in Neurology. 9: 224-33. PMID 17445500 DOI: 10.1007/BF02938412  0.96
2007 Andresen JM, Gayán J, Djoussé L, Roberts S, Brocklebank D, Cherny SS, Cardon LR, Gusella JF, MacDonald ME, Myers RH, Housman DE, Wexler NS. The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Annals of Human Genetics. 71: 295-301. PMID 17181545 DOI: 10.1111/j.1469-1809.2006.00335.x  0.96
2007 Nichols WC, Marek DK, Pauciulo MW, Pankratz N, Halter CA, Rudolph A, Shults CW, Wojcieszek J, Foroud T, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, ... ... Higgins D, et al. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation Movement Disorders. 22: 254-257. PMID 17149721 DOI: 10.1002/mds.21233  0.96
2006 Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, ... ... Higgins D, et al. Mutations in LRRK2 other than G2019S are rare in a north-American based sample of familial Parkinson's didease Movement Disorders. 21: 2257-2260. PMID 17078063 DOI: 10.1002/mds.21162  0.96
2006 Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. The Lancet. Neurology. 5: 917-23. PMID 17052658 DOI: 10.1016/S1474-4422(06)70579-8  0.96
2006 Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, Payami H. Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genetic Testing. 10: 221-7. PMID 17020475 DOI: 10.1089/gte.2006.10.221  0.96
2006 Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. American Journal of Human Genetics. 79: 752-8. PMID 16960813 DOI: 10.1086/508025  0.96
2006 Higgins DS. Huntington's Disease. Current Treatment Options in Neurology. 8: 236-44. PMID 16569382 DOI: 10.1007/s11940-006-0014-x  0.96
2006 Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology. 66: 411-4. PMID 16476942 DOI: 10.1212/01.wnl.0000196469.52995.ab  0.96
2006 Kay DM, Zabetian CP, Factor SA, Nutt JG, Samii A, Griffith A, Bird TD, Kramer P, Higgins DS, Payami H. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 519-23. PMID 16250030 DOI: 10.1002/mds.20751  0.96
2005 Kay DM, Kramer P, Higgins D, Zabetian CP, Payami H. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1077-8. PMID 16001413 DOI: 10.1002/mds.20618  0.96
2005 Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/mds.20332  0.96
2004 Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, ... ... Higgins DS, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America. 101: 3498-503. PMID 14993615 DOI: 10.1073/pnas.0308679101  0.96
2003 Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I. Predictors of nursing home placement in Huntington disease. Neurology. 60: 998-1001. PMID 12654967  0.96
2001 Higgins DS. Chorea and its disorders. Neurologic Clinics. 19: 707-22, vii. PMID 11532650 DOI: 10.1016/S0733-8619(05)70041-4  0.96
2000 Talpade DJ, Greene JG, Higgins DS, Greenamyre JT. In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. Journal of Neurochemistry. 75: 2611-21. PMID 11080215 DOI: 10.1046/j.1471-4159.2000.0752611.x  0.96
2000 Hoyt KR, McLaughlin BA, Higgins DS, Reynolds IJ. Inhibition of glutamate-induced mitochondrial depolarization by tamoxifen in cultured neurons. The Journal of Pharmacology and Experimental Therapeutics. 293: 480-6. PMID 10773018  0.96
1999 Higgins DS, Hoyt KR, Baic C, Vensel J, Sulka M. Metabolic and glutamatergic disturbances in the Huntington's disease transgenic mouse. Annals of the New York Academy of Sciences. 893: 298-300. PMID 10672253  0.96
1997 Kilbourn MR, Charalambous A, Frey KA, Sherman P, Higgins DS, Greenamyre JT. Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 265-72. PMID 9119899 DOI: 10.1097/00004647-199703000-00003  0.96
1996 Higgins DS, Greenamyre JT. [3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 3807-16. PMID 8656275  0.96
1995 Charalambous A, Tluczek L, Frey KA, Higgins DS, Greenamyre TJ, Kilbourn MR. Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. Nuclear Medicine and Biology. 22: 491-6. PMID 7550026 DOI: 10.1016/0969-8051(94)00129-8  0.96
1994 Albin RL, Howland MM, Higgins DS, Frey KA. Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain. Neurochemical Research. 19: 581-9. PMID 8065514 DOI: 10.1007/BF00971334  0.96
1994 Porter RH, Greene JG, Higgins DS, Greenamyre JT. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 7192-9. PMID 7965108  0.96
1992 Greenamyre JT, Higgins DS, Eller RV. Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain. Journal of Neurochemistry. 59: 746-9. PMID 1629744  0.96
1991 Albin RL, Sakurai SY, Makowiec RL, Higgins DS, Young AB, Penney JB. Excitatory amino acid, GABA(A), and GABA(B) binding sites in human striate cortex. Cerebral Cortex (New York, N.Y. : 1991). 1: 499-509. PMID 1668367 DOI: 10.1093/cercor/1.6.499  0.96
1990 Greenamyre JT, Higgins DS, Young AB, Penney JB. Regional ontogeny of a unique glutamate recognition site in rat brain: an autoradiographic study. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 8: 437-45. PMID 2174635 DOI: 10.1016/0736-5748(90)90076-E  0.96
1990 Greenamyre JT, Higgins DS, Young AB. Sodium-dependent D-aspartate 'binding' is not a measure of presynaptic neuronal uptake sites in an autoradiographic assay. Brain Research. 511: 310-8. PMID 2159361 DOI: 10.1016/0006-8993(90)90176-C  0.96
1986 Hassan MN, Reches A, Kuhn C, Higgins D, Fahn S. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide Clinical Neuropharmacology. 9: 71-78. PMID 3829008  0.96
1986 Hassan MN, Higgins D, Traub M, Fahn S. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats Life Sciences. 39: 513-518. PMID 3090394 DOI: 10.1016/0024-3205(86)90507-2  0.96
Show low-probability matches.